About Embase - Biomedical Database
- 25 million indexed records, drawn from over 7,600 journals.
- All of Medline included.
- 5 million records and 2,000 journals not covered by Medline also included.
- Over 1,800 journal titles provide a data feed of not-yet-published Articles in Press.
- More than 5,000 titles deliver not-yet-fully-indexed In Process records.
- Access 2,500+ conferences and more than 800,000 conference abstracts. Each year, over 300,000 new conference abstracts are indexed.
- Locate almost 2 million biomedical and pharmacological citations, drawn from over 3,000 international titles.
Find quick, accurate answers to your biomedical research questions
Embase’s comprehensive journal and conference coverage, together with in-depth drug indexing and daily updates, supports tracking and precise retrieval of drug and disease information.
From preclinical study to the search for important toxicological information, Embase offers the confidence and tools you need to capture the most relevant and up-to-date biomedical study research.
Biomedical Science Literature.
If you're searching MEDLINE, you're only seeing part of the picture. Embase holds millions of indexed records from thousands of active, authoritative journals, including all of MEDLINE as well as 5 million+ records and 2,000 biomedical journals not currently covered by MEDLINE. With Embase’s broad-ranging, authoritative coverage, you can be confident that you are not missing any critical drug and disease information from the literature.
Deep Indexing.
With the life science thesaurus Emtree.
Embase is deeply and consistently indexed by experts, using our unique thesaurus Emtree.⨠Emtree allows you to find the exact biomedical information you are looking for, without irrelevant or misleading results. Embase’s drug indexing is underpinned by chemical names, trade names, and laboratory/research codes that are mapped to generic names for more than 30,000 drugs and chemicals, so you can search for a drug by any name that is known to you. Read more about Emtree
In-depth Coverage.
With Embase, knowledge is universal.
Embase indexes articles published in over 90 countries and 40 languages, with the database growing at a rate of over 1 million records a year. The result is an exhaustive biomedical database that assists research in pharmacology, research in microbiology, biotechnology research, research in diabetes, and much more.
Click here for an annual summary of journals covered by Embase.
The majority of journal titles are peer-reviewed, with new journal titles being added to the collection regularly, so if you have a journal title that you think should be included, please complete our Journal Title Suggestion Form.
Articles in Press and In Process records
In order to provide a level of currency better even than the fully indexed Embase records, Embase includes Articles in Press as well as records that are “In Process” (not yet fully indexed). Both Articles in Press and In Process records are automatically indexed in advance of comprehensive full text indexing in order to ensure that the most important concepts are retrievable in Emtree searches.
Conference Coverage
Embase contains conferences and conference abstracts published in journals and journal supplements since 2009. As thousands of new conference abstracts from conferences covering the entire scope of Embase are indexed, Embase is unique in its extensive coverage of biomedical conference abstracts.
For a summary of conferences loaded on Embase up to 1 January 2013, click here. To prepare a list of conferences covered on Embase after this date, use the Conference Review publication type limited to data loaded since 1 January 2013.
Click here for an up to date summary of conferences covered by Embase.
Discover New Possibilities in the Past
Historic biomedical research from Embase Classic.
Our fully digitized back file covers valuable data published between 1947 and 1973. Use Embase Classic for adverse drug reaction monitoring on old drugs, to find new uses for old drugs, to retrieve biomedical articles for litigation purposes, and to review the history of approved uses for drugs.
